Targeted Suppression of CEACAM6 via pHLIP-Delivered RNAs in Pancreatic Ductal Adenocarcinoma

Targeted Suppression of CEACAM6 via pHLIP-Delivered RNAs in Pancreatic Ductal Adenocarcinoma

<i>Background and Objectives</i>: Carcinoembryonic antigen-related cell adhesion molecule 6 (CEACAM6) is involved in pancreatic cancer progression and is an attractive therapeutic target for pancreatic cancer. In this study, we evaluated the therapeutic efficacy of small-interfering RNA...

Full description

Saved in:

Bibliographic Details
Main Authors:	Hongsik Kim, Chang-Gok Woo, Seung-Myoung Son, Yong-Pyo Lee, Hee-Kyung Kim, Yaewon Yang, Jihyun Kwon, Ki-Hyeong Lee, Ho-Chang Lee, Ok-Jun Lee, Hye-Sook Han
Format:	Article
Language:	English
Published:	MDPI AG 2025-03-01
Series:	Medicina
Subjects:	pancreatic ductal adenocarcinoma pHLIP CEACAM6 drug delivery tumor acidity
Online Access:	https://www.mdpi.com/1648-9144/61/4/598
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Development of a radiomic model to predict CEACAM1 expression and prognosis in ovarian cancer
by: Xiaoxue Zhang, et al.
Published: (2025-04-01)

CEA (CEACAM5) expression is common in muscle‐invasive urothelial carcinoma of the bladder but unrelated to the disease course
by: Henning Plage, et al.
Published: (2024-06-01)

Diagnostic value of CEACAM6 and HE4 in pleural fluid for malignant pleural effusion
by: Jie Li, et al.
Published: (2025-12-01)

Safety of unconventional antibody-drug conjugate L-DOS47 in a phase I/II monotherapy study targeting advanced NSCLC
by: Rodryg Ramlau, et al.
Published: (2025-08-01)

Rapid diagnostic imaging and targeted immunotoxin delivery in aggressive prostate cancer using CEACAM5-specific nanobodies
by: Zhaoming Xiao, et al.
Published: (2025-07-01)

Improved acid-driven inhibition of effector T cell function by a pHLIP variant-conjugated PD-L1
by: Hang Zheng, et al.
Published: (2025-04-01)

Chronic Exposure of Renal Progenitor Cells (HRTPT) to As (III) Implicates Microfibril Associated Protein 5 (MFAP5) in the Activation of Carcinoembryonic Antigen Related Cell Adhesion Molecules (CEACAM 5 and 6)
by: Md Ehsanul Haque, et al.
Published: (2025-06-01)

A retrospective observational study of tetralogy of fallot with pulmonary atresia and ductal-dependent pulmonary circulation focusing on the staged transannular patch procedure: a single-center study
by: Jae Hong Lee, et al.
Published: (2025-07-01)

Assessment of Human Epididymis Protein 4 Expression in Breast Ductal Carcinoma In Situ
by: Nah Ihm Kim, et al.
Published: (2025-04-01)

Association of clinico-pathological and immunohistochemical prognostic parameters with presence of ductal carcinoma in-situ in an invasive ductal carcinoma of breast
by: Dhivya Balaiya, et al.
Published: (2023-12-01)

Markers of Hepatic Insulin Clearance and Their Association With Steatosis in Hyperinsulinaemic Horses
by: Miranda Dosi, et al.
Published: (2025-07-01)

Biochemical analysis of packing and assembling heptad repeat motifs in the coronavirus spike protein trimer
by: Jun Kobayashi, et al.
Published: (2024-11-01)

Inhibition of cancer cells using target-specific 2A3 antibody-conjugated gold nanoclusters
by: Jui-Chi Kuo, et al.
Published: (2022-03-01)

DIFFICULTIES OF DIAGNOSTICS AND CHOICE OF SURGICAL APPROACH IN PATIENTS WITH DUCTAL CHOLANGIOCARCINOMA
by: D. A. Granov, et al.
Published: (2017-02-01)

Ductal Carcinoma In Situ of the Breast in Sclerosing Adenosis Mimicking Microinvasive Ductal Carcinoma: A Rare Case Report
by: Yu‐Kai Chang, et al.
Published: (2024-12-01)

Epigenetic Landscape of DNA Methylation in Pancreatic Ductal Adenocarcinoma
by: Peiyi Liu, et al.
Published: (2024-11-01)

Contribution of gut microbiome to pancreatic ductal adenocarcinoma development
by: D. V. Zaitsev, et al.
Published: (2025-05-01)

Single vein resection in surgery for pancreatic ductal carcinoma as a criterion of resectability
by: D. A. Chichevatov, et al.
Published: (2022-09-01)

Immunohistochemical Evaluation of the Tumor Immune Microenvironment in Pancreatic Ductal Adenocarcinoma
by: Gelu Mihai Breaza, et al.
Published: (2025-03-01)

Genomic features of liquid biopsies from patients with prostate cancer with and without ductal adenocarcinoma
by: Qiyu Zhu, et al.
Published: (2025-05-01)

HOXA9 and CD163 potentiate pancreatic ductal adenocarcinoma progression
by: Aiat Shaban Hemida, et al.
Published: (2024-10-01)

Exploration of the breast ductal carcinoma in situ signature and its prognostic implications
by: Jiao Zhang, et al.
Published: (2023-02-01)

Identification of Tumor‐Specific Surface Proteins Enables Quantification of Extracellular Vesicle Subtypes for Early Detection of Pancreatic Ductal Adenocarcinoma
by: Chen Zhao, et al.
Published: (2025-06-01)

Prognostic significance of ımmunhistochemical axl expression in pancreas ductal adenocarcinomas
by: Ozden Oz, et al.
Published: (2023-07-01)

Clinical application of combined CT radiomics and clinical features in survival prediction for pancreatic ductal adenocarcinoma patients
by: LI Ke, et al.
Published: (2025-07-01)

Epigenetic evolution and clinicopathological implications of distinct DNA methylation profiles in pancreatic ductal adenocarcinoma
by: Keiichiro Kitahama, et al.
Published: (2025-08-01)

Cancer stem cells and mesenchymal stem cells in pancreatic ductal adenocarcinoma
by: V. O. Tumanskyi, et al.
Published: (2019-06-01)

Long-term survival with repeat resection for lung oligometastasis from pancreatic ductal adenocarcinoma: a case report
by: Ryota Matsuki, et al.
Published: (2018-03-01)

The scRNA-sequencing landscape of pancreatic ductal adenocarcinoma revealed distinct cell populations associated with tumor initiation and progression
by: Ying Wang, et al.
Published: (2025-05-01)

Targeting Ischemia-reperfusion injury in liver transplant rejuvenation
by: Kenneth J. Dery, et al.
Published: (2025-06-01)

Diagnostic and therapeutic recommendations in pancreatic ductal adenocarcinoma. Recommendations of the Working Group of the Polish Pancreatic Club
by: Katarzyna Winter, et al.
Published: (2019-03-01)

A stochastic model for evaluating the progression of ductal carcinoma in situ breast cancer using Norwegian breast cancer screening program data
by: Xiaoxue Li, et al.
Published: (2025-01-01)

The Clonal Trajectory of Liver and Lung Metastases in Pancreatic Ductal Adenocarcinoma
by: Ofer N. Gofrit, et al.
Published: (2025-05-01)

FEATURES OF ISLET-LIKE CLUSTERS GENERATION IN PANCREATIC DUCTAL CELL MOLOLAYER CULTURING
by: L. A. Kirsanova, et al.
Published: (2012-12-01)

Neoadjuvant Stereotactic Ablative Radiotherapy in Pancreatic Ductal Adenocarcinoma: A Review of Perioperative and Long-Term Outcomes
by: Robert Michael O’Connell, et al.
Published: (2025-07-01)

Concurrent Invasive Ductal Carcinoma and Pancreatic Intraepithelial Neoplasia in Duodenal Heterotopic Pancreas: A Case Report
by: Sara Al Harthi, et al.
Published: (2024-11-01)

Targeting BARD1 suppresses a Myc-dependent transcriptional program and tumor growth in pancreatic ductal adenocarcinoma
by: Sohum Patel, et al.
Published: (2025-05-01)

Consensus statement on the use of systemic therapies in pancreatic ductal adenocarcinoma in Asia
by: D.-Y. Oh, et al.
Published: (2025-06-01)

Combination of imaging features on pancreatic CT for predicting early recurrence after upfront pancreatoduodenectomy of pancreatic ductal adenocarcinoma
by: Shuanglin Zhang, et al.
Published: (2025-12-01)

Pancreatic ductal adenocarcinoma with inferior vena cava invasion: a report of three resected cases
by: Takuya Mizumoto, et al.
Published: (2017-05-01)